BEXION PHARMACEUTICALS, INC.
Biotech · Private
BXQ-350, a proteolipid nanovesicle therapeutic composed of saposin C and phospholipid that targets and induces ceramide-mediated death in glioblastoma tumor cells
- Grants
- $949K
- 1 award
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 11
- 3 granted · 8 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20152016
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase II · SapC-DOPS Nanovesicles for Treating Glioblastoma Multiforme | $948,501 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1493 | SynPhaGen, LLC | — | — |
| 1494 | MITOSENSE, INC. | — | $2.2M |
| 1495 | GFREE BIO, LLC | — | — |
| 1496 | BEXION PHARMACEUTICALS, INC. | — | — |
| 1497 | Viewpoint Therapeutics, Inc. | — | $25M |
| 1498 | Enzyme by Design Inc. | — | — |
| 1499 | Calporta Therapeutics | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Saposin C Pharmaceutical Compositions And Methods Of Treating Cancergranted
- Methods Of Reducing Neuropathy And Neuropathic Symptoms And Treating Cancerapplication
- Antiviral Compositions And Methodsapplication
- Saposin C Pharmaceutical Compositions And Methods Of Treating Cancergranted
- Saposin C Pharmaceutical Compositions And Methods Of Treating Cancergranted
- Methods for Treating Gastrointestinal Cancerapplication
- Saposin C Pharmaceutical Compositions And Methods Of Treating Cancerapplication
- Antiviral Compositions And Methodsapplication
- Methods Of Reducing Neuropathy And Neuropathic Symptoms And Treating Cancerapplication
- Methods for Treating Cancerapplication
- Methods Of Reducing Neuropathy And Neuropathic Symptomsapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.